Real-time enrollment status for this peripheral lung tumor clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 9:30 AM UTC
| NCT Number | NCT05918783 |
| Recruiting Status | Recruiting |
| Condition | Peripheral Lung Tumor |
| Phase | PHASE1 |
| Target Enrollment | 36 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Impact Biotech Ltd |
| Last Updated on CT.gov | February 11, 2025 (Feb 11, 2025) |
As of July 19, 2026: Clinical trial NCT05918783 is currently recruiting participants. This phase1 study for peripheral lung tumor is actively seeking new participants at 1 location across the United States. The study is sponsored by Impact Biotech Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05918783 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05918783 was last updated Feb 11, 2025 (February 11, 2025). HelloStudys verifies this status automatically.